9.1
Telehealth GLP-1 programme with genuine clinical follow-up
$299/monthHighly recommended
#5 of 12 overallPrescriptionPrescription required
Northline Health review
by Northline
Roughly half the monthly cost of the leaders, achieved by prescribing compounded semaglutide and running follow-up through asynchronous messaging. Legitimate, cheaper, and meaningfully less supervised than what the trials studied.
7.4Recommended
Last updated · used for 14 weeks · reviewed by Tom
Disclosure: We have an affiliate relationship with Northline. If you buy through a link on this page we may be paid a commission, at no additional cost to you. We bought and used this product ourselves, and Northline had no involvement in this review, no advance copy, and no ability to change the score. Full disclosure
Tom’s verdict
This is the compromise product in the category and you should understand exactly what you are compromising. Compounded medication is made by pharmacies under a different regulatory pathway than FDA-approved drugs — it is not counterfeit, but it has not been through the approval process, and batch consistency is not guaranteed the same way. Northline is upfront that it is compounded, which many competitors are not. But the faster titration and the absence of any real clinical touchpoint after intake are what is paying for the lower price, and that is a trade I would want made deliberately rather than by default.
What we liked and what we didn’t
Strengths
- All-in pricing that includes medication — genuinely simpler than the competition
- Intake reviewed within 24 hours in our test
- Messaging support answered within a day every time we used it
- No hard upsell during onboarding
Problems
- Compounded semaglutide is not FDA-approved and is not the product the trials tested
- Follow-up is asynchronous messaging only — no scheduled clinical review
- Three-month prepayment means your refund exposure is $447, not $149
- Nothing offered about tapering or what happens after you stop
- Titration schedule was faster than the labelling for the approved equivalent
Best for
Cost-constrained people who have discussed compounded medication specifically with their own doctor and understand the distinction.
Not for
Anyone who assumes compounded means the same thing as approved, or who wants a clinician actively monitoring them.
What the evidence actually shows
The evidence base for semaglutide is strong, but it was generated using the FDA-approved product. Compounded versions are not required to demonstrate equivalence, and the FDA has issued warnings about dosing errors associated with compounded GLP-1 products. We score evidence lower here not because the molecule is unproven but because what Northline ships is not what was tested.
Compounded is not a synonym for generic
This is the single most misunderstood thing in the category. A generic drug has demonstrated bioequivalence to an approved product. A compounded drug has not — it is prepared by a pharmacy, legally, but outside the approval process.
Northline discloses this in its FAQ. It does not disclose it during the flow where you agree to pay, and we think it should.
Where the money is saved
The $149 all-in price is real and it is roughly half what supervised alternatives cost. The savings come from two places: compounded rather than branded medication, and asynchronous messaging rather than scheduled clinical review.
The first is a regulatory trade-off. The second is a supervision trade-off. Both are defensible for the right person; neither is invisible.
Others in prescription
3.8
Prescription access with almost no medical process attached
$129/monthAvoid